The PACT (Patient Activation Through Conversations) Study

Launched by NATIONAL HEALTHCARE GROUP POLYCLINICS · May 30, 2024

Keywords

ClinConnect Summary

The PACT Study is looking at how a special health coaching program can help people with type 2 diabetes better manage their condition. This program involves working with trained health coaches who guide participants over three months to set personal health goals, understand their diabetes better, and improve their self-care habits. The main focus of the study is to see if this coaching approach leads to lower blood sugar levels, measured by a test called HbA1c, over time compared to those receiving standard care for diabetes.

To join the study, you need to be between 21 and 64 years old, have a diagnosis of type 2 diabetes, and have had a blood sugar level (HbA1c) above 8% in the last six months. The study is currently recruiting participants, and if you qualify, you will receive support through phone or messaging to help you stay on track with your diabetes management. This trial aims to find out if personal coaching can make a real difference in managing diabetes and improving overall health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals with a diagnosis of Type 2 Diabetes Mellitus who are enrolled in Teamlets in NHGP
• • Age between 21 to 64 years old
• • HbA1c level of more than 8% in the last 6 months
• Exclusion Criteria:
• • History of acute coronary syndrome in the past 3 months
• • History of stroke or transient ischaemic attacks in the past 3 months
• • History of end stage organ failure (liver cirrhosis, cardiac failure, latest eGFR \<30 mL/min/1.73m2 in the last 6 months)
• • Cancer requiring treatment in the past 5 years.
• • Active psychiatrist follow up
• • Social issues that are significant enough for follow-up or referral with a medical social worker within the last 12 months
• • Women who are pregnant or breastfeeding
• • Patients who are enrolled in other current diabetes-related interventional studies
• • Inability to provide written consent for the study protocol and able to commit to the study duration.

Trial Officials